Hemorrhagic stroke happens when a blood vessel in the brain ruptures and bleeds into surrounding tissue. It accounts for about 35% of all strokes worldwide, split between bleeding within the brain itself (intracerebral hemorrhage, roughly 29% of strokes) and bleeding in the space surrounding the brain (subarachnoid hemorrhage, about 6%). The causes range from decades of high blood pressure to sudden drug-induced spikes, structural defects in blood vessels, and age-related protein buildup in artery walls.
High Blood Pressure Is the Leading Cause
Chronic hypertension is responsible for more hemorrhagic strokes than any other factor. The damage unfolds over years. Sustained high pressure forces plasma proteins into the walls of the brain’s smallest arteries, thickening and stiffening them in a process called hyaline arteriosclerosis. Over time, the smooth muscle cells that give these tiny vessels their flexibility degenerate. The elastic layers break down, and the vessel walls weaken.
This weakening produces Charcot-Bouchard microaneurysms, tiny balloon-like bulges on the penetrating arteries deep in the brain. These microaneurysms are most common in the basal ganglia and brainstem, which is why hypertension-related hemorrhages tend to occur in those deep brain structures rather than near the surface. There’s a dose-response relationship: the higher and longer your blood pressure stays elevated, the more microbleeds and structural damage accumulate.
What makes this especially dangerous is the interaction between long-term vessel damage and short-term blood pressure spikes. Research shows that recent blood pressure elevations, within a year or less, are strongly associated with acute brain hemorrhage. In other words, someone who has years of vessel damage from chronic hypertension and then experiences a sudden pressure surge is at the highest risk for rupture.
Amyloid Buildup in Aging Blood Vessels
In people over 65, a condition called cerebral amyloid angiopathy (CAA) becomes one of the most important causes of spontaneous brain hemorrhage. CAA occurs when fragments of a protein called amyloid beta accumulate in the walls of small and medium-sized arteries near the brain’s surface. This buildup is caused either by overproduction of the protein or, more commonly, by the brain’s declining ability to clear it with age.
As amyloid deposits thicken, the vessel walls become brittle and fragile. The resulting hemorrhages look different from hypertension-related bleeds: they occur in lobar locations (the outer regions of the brain), especially toward the back of the head, rather than in the deep structures. CAA is a major cause of recurrent brain hemorrhages in older adults. Genetics play a significant role in who develops the condition. Variants of the APOE gene are implicated in more than half of all CAA patients. Carrying the APOE ε4 variant increases both the likelihood and severity of amyloid deposits, and it raises the risk of early hemorrhagic episodes.
Aneurysms and Malformed Blood Vessels
Structural abnormalities in brain blood vessels can cause hemorrhagic stroke at any age. The two most common are aneurysms and arteriovenous malformations (AVMs).
A brain aneurysm is a weakened, bulging spot on an artery wall. Most are small and cause no symptoms, but when one ruptures, blood spills into the space around the brain, causing subarachnoid hemorrhage. Aneurysms often form at branching points where arteries divide, and they can grow slowly over years before rupturing, sometimes triggered by sudden physical exertion or a blood pressure spike.
AVMs are tangles of abnormal connections between arteries and veins that bypass the normal capillary network. Because blood flows directly from high-pressure arteries into low-pressure veins, the vessels within an AVM are under constant strain. These tangles can develop pseudoaneurysms, weak points that mark the exact location where a vessel is most likely to tear. Rupture can occur on either the arterial or venous side of the malformation. When surgery is performed shortly after a hemorrhage, surgeons often find dilated veins partially filled with clot at the rupture site.
Blood Thinners and Medication Risks
Anticoagulant medications, which reduce the blood’s ability to clot, increase the risk of brain hemorrhage. This risk is not equal across drug types. Older blood thinners like warfarin carry a significantly higher risk of intracranial hemorrhage compared to newer direct oral anticoagulants. In patients who already have tiny microbleeds in the brain, warfarin users face roughly four times the risk of a major brain bleed compared to those on newer anticoagulants.
Warfarin use is also associated with a higher prevalence of those microbleeds in the first place. Newer anticoagulants don’t show the same association. This distinction matters for people taking blood thinners for conditions like atrial fibrillation, where the medication prevents clot-based strokes but carries a tradeoff of increased bleeding risk. If someone on blood thinners does experience a brain hemorrhage and the underlying cause is identified and treated, guidelines generally recommend restarting anticoagulation after two to four weeks, with newer agents as the preferred choice.
Cocaine, Amphetamines, and Stimulant Drugs
Stimulant drugs are a well-documented trigger for hemorrhagic stroke, particularly in younger adults. Cocaine and methamphetamine cause brain hemorrhages through several overlapping mechanisms. The most immediate is acute hypertension: these drugs spike blood pressure rapidly and dramatically, creating the kind of sudden surge that can rupture already-weakened vessels or even healthy ones under enough force.
Beyond the pressure spike, stimulants cause intense vasoconstriction, narrowing blood vessels throughout the brain. Cocaine in particular is linked to aneurysm formation and rupture. The rate of aneurysm-related subarachnoid hemorrhage is significantly elevated in cocaine users. Amphetamines, including substances marketed as diet pills with amphetamine-like compounds, can trigger the same cascade of vasoconstriction and transient blood pressure elevation that leads to vessel rupture. Repeated use compounds the risk by progressively damaging vessel walls, even between episodes of active drug use.
How Hemorrhagic Stroke Is Detected
A non-contrast CT scan of the head is the first-line tool for diagnosing hemorrhagic stroke because it can quickly and reliably identify active bleeding. Fresh blood appears bright white on CT, making it easy to distinguish from the surrounding brain tissue within minutes of the scan. This speed is critical because the treatment for a hemorrhagic stroke is the opposite of treatment for a clot-based stroke, so identifying the type fast directly affects what happens next.
MRI is more sensitive for detecting subtle changes in brain tissue and is better at identifying underlying causes like small vessel disease, old microbleeds, or amyloid deposits. However, it takes longer to perform and isn’t always available in emergency settings, which is why CT remains the standard first step.
What Happens in the First Hours
When a brain vessel ruptures, blood pools rapidly in the surrounding tissue, forming a clot called a hematoma. This mass of blood compresses nearby brain cells and raises pressure inside the skull. The damage comes from two sources: the direct destruction of brain tissue where the blood collects, and the secondary injury caused by swelling and pressure on adjacent healthy areas.
One of the most urgent priorities in the first hours is controlling blood pressure to limit further bleeding and hematoma expansion. Clinical guidelines converge on lowering systolic blood pressure to around 140 mmHg in patients who present with levels between 150 and 220. For those arriving with extremely high readings above 220, more aggressive reduction with continuous monitoring is recommended. European guidelines specifically target this window within the first six hours, aiming to keep systolic pressure below 140 but above 110 to maintain adequate blood flow to the brain.
Hemorrhagic stroke carries a high mortality rate, and survivors face a meaningful risk of recurrence. About 2 to 3% of people who survive a first stroke experience another one within 30 days, and 10 to 16% have a recurrence within the first year. Identifying and addressing the underlying cause, whether it’s uncontrolled blood pressure, a structural abnormality, or a medication issue, is the most important factor in reducing that risk.